Works matching IS 15233790 AND DT 2022 AND VI 24 AND IP 4
Results: 14
Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 348, doi. 10.1007/s11864-022-00954-4
- By:
- Publication type:
- Article
Venous Thrombotic Events and Anticoagulation in Brain Tumor Patients.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 493, doi. 10.1007/s11912-021-01178-9
- By:
- Publication type:
- Article
Lysophosphatidic acid receptor 6 regulated by miR-27a-3p attenuates tumor proliferation in breast cancer.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 503, doi. 10.1007/s12094-021-02704-8
- By:
- Publication type:
- Article
Cancer Therapies and Vascular Toxicities.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 333, doi. 10.1007/s11864-022-00964-2
- By:
- Publication type:
- Article
Pathogenesis and Amelioration of Radiation-Induced Oral Mucositis.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 311, doi. 10.1007/s11864-022-00959-z
- By:
- Publication type:
- Article
Role of Virus-Directed Therapy in Soft Tissue Sarcoma.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 404, doi. 10.1007/s11864-022-00956-2
- By:
- Publication type:
- Article
Human umbilical cord mesenchymal stem cell-derived exosomes carrying hsa-miRNA-128-3p suppress pancreatic ductal cell carcinoma by inhibiting Galectin-3.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 517, doi. 10.1007/s12094-021-02705-7
- By:
- Publication type:
- Article
Which FLT3 Inhibitor for Treatment of AML?
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 359, doi. 10.1007/s11864-022-00952-6
- By:
- Publication type:
- Article
HPV as a Carcinomic Driver in Head and Neck Cancer: a De-escalated Future?
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 325, doi. 10.1007/s11864-022-00950-8
- By:
- Publication type:
- Article
Immunotherapy and Biomarkers in Sarcoma.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 415, doi. 10.1007/s11864-022-00944-6
- By:
- Publication type:
- Article
Reirradiation of Recurrent and Second Primary Cancers of the Head and Neck: a Review of the Contemporary Evidence.
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 295, doi. 10.1007/s11864-021-00936-y
- By:
- Publication type:
- Article
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL).
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 381, doi. 10.1007/s11864-021-00932-2
- By:
- Publication type:
- Article
What Clinical Trials Are Needed for Treatment of Leiomyosarcoma?
- Published in:
- Current Oncology Reports, 2022, v. 24, n. 4, p. 439, doi. 10.1007/s11864-021-00928-y
- By:
- Publication type:
- Article
Correction to: Cancer-Related Fatigue: Causes and Current Treatment Options.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice